Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
(→S) (Tags: Mobile edit, Mobile web edit) |
|||
| Line 21: | Line 21: | ||
*[[Absolute risk]] | *[[Absolute risk]] | ||
| + | |||
| + | *[[Absorbed dose]], D | ||
| + | |||
| + | *[[Absorbed fraction]] | ||
| + | |||
| + | *[[Absorption]] | ||
*[[Accelerated fractionation]] | *[[Accelerated fractionation]] | ||
| Line 31: | Line 37: | ||
*[[Action Level]] | *[[Action Level]] | ||
| + | |||
| + | *[[Activation]] | ||
*[[Active (red) bone marrow]] | *[[Active (red) bone marrow]] | ||
| + | |||
| + | *[[Activity]] | ||
*[[Activity median thermodynamic diameter]] | *[[Activity median thermodynamic diameter]] | ||
| Line 59: | Line 69: | ||
*[[Air-kerma, product]] | *[[Air-kerma, product]] | ||
| + | |||
| + | *ALI (see [[Annual limit on intake]]) | ||
*[[Alimentary tract]] | *[[Alimentary tract]] | ||
| Line 67: | Line 79: | ||
*[[Alveolar-interstitial region]] | *[[Alveolar-interstitial region]] | ||
| + | |||
| + | *AMAD (see [[Activity median aerodynamic diameter]]) | ||
| + | |||
| + | *[[Ambient dose equivalent]], H*(10) | ||
*[[Angiogenesis]] | *[[Angiogenesis]] | ||
| Line 73: | Line 89: | ||
*[[Annual dose]] | *[[Annual dose]] | ||
| + | |||
| + | *[[Annual intake]] | ||
| + | |||
| + | *[[Annual limit on intake]] | ||
*[[Area monitoring]] | *[[Area monitoring]] | ||
Revision as of 14:16, 28 March 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. Some entries include historical descriptions to help readers better understand the term in a particular context.
It is a living document, updated regularly.
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
A
- Acute radiation sickness (see Acute radiation syndrome)
- ALI (see Annual limit on intake)
- AMAD (see Activity median aerodynamic diameter)
- Ambient dose equivalent, H*(10)
- ARS (see Acute radiation syndrome)
B
- BAT (see Best available techniques)
C
D
- DD (see Doubling dose)
- DDREF (see Dose and dose-rate effectiveness factor)
E
- EAR (see Excess absolute risk)
- ELR (i.e. Excess Lifetime Risk, see Lifetime risk estimates)
- ERR (see Excess relative risk)
- Excess lifetime risk (see Lifetime risk estimates)
F
G
H
I
- Incidence rate (see Incidence)
J
K
L
- LLE (see Lifetime risk estimates)
- Loss of Life Expectancy (see Lifetime risk estimates)
- LSS (see Life Span Study)
M
N
- NHEJ (see Non-homologous end joining)
O
P
- PLDR (see Potentially lethal damage repair)
Q
R
- Radiation detriment (see Detriment)
- RAP (see Reference Animal and Plant)
- RBE (see Relative biological effectiveness)
- REID (see Lifetime risk estimates)
- Risk of exposure-induced death (see (see Lifetime risk estimates)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- SLDR (see Sublethal damage repair)
- Source (see Radiation source)
T
- Transport of risk (see Transfer of risk)
U
V
W
- wT (see Tissue weighting factor)
- wR (see Radiation weighting factor)
X
Y
Z
...
- α/β ratio (see α/β value)
